Catalyst Funds Management Pty »

Regeneron Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-09-30 $956k 1.7k 562.27
2024-03-31 $385k 400 962.49

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Morgan Stanley
Goldman Sachs Group
Nuveen

View all funds holding Regeneron Pharmaceuticals